Showing 4911-4920 of 5771 results for "".
- Santen Receives Canadian Drug Expert Committee Reimbursement Recommendation for Verkazia Eye Dropshttps://modernod.com/news/santen-receives-canadian-drug-expert-committee-reimbursement-recommendation-for-verkazia-eye-drops/2477114/Santen Canada announced that the Canadian Agency for Drugs and Technologies in Health (CADTH) Canadian Drug Expert Committee (CDEC) released a reimbursement recommendation for Verkazia (cyclosporine 0.1%) eye drops. This reimbursement recommendation marks an important step towards providin
- ProtoKinetix AAGP Dry Eye Therapy Program Launchedhttps://modernod.com/news/protokinetix-aagp-dry-eye-therapy-program-launched/2477115/ProtoKinetix announces the initiation of a program testing AAGP to develop a potential therapy to treat dry eye disease (DED). AAGP has demonstrated anti-inflammatory and cytoprotective properties, and also exhibits pharmaceutical properties beneficial for topical formulations, according to a com
- ProQR Receives Orphan Drug Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosahttps://modernod.com/news/proqr-receives-orphan-drug-designation-from-fda-for-qr-1123-for-autosomal-dominant-retinitis-pigmentosa/2477112/ProQR Therapeutics announced that it received orphan drug designation (ODD) from the FDA for QR-1123, a first-in-class investigational antisense oligonucleotide designed to address the underlying cause of vision loss associated with autosomal dominant retinitis pigmentosa (adRP) due to the P23H m
- EnChroma Makes New Indoor Color Blind Glasses Available to the Publichttps://modernod.com/news/enchroma-makes-new-indoor-color-blind-glasses-available-to-the-public/2477109/EnChroma announced the launch of EnChroma Cx1 Indoor DT, an improved indoor lens designed specifically for Deutan-type color blindness. The glasses are now available for purchase online at
- Glaukos Completes Acquisition of Avedrohttps://modernod.com/news/glaukos-completes-acquisition-of-avedro/2477110/Glaukos announced that it has completed its previously announced acquisition of Avedro. In August, Glaukos agreed to acquire cross-linking company Avedro in an all-stock transaction. Under the terms of the
- Aerie Pharmaceuticals Receives European Commission Approval for Glaucoma Drug Rhokiinsahttps://modernod.com/news/aerie-pharmaceuticals-receives-european-commission-approval-for-glaucoma-drug-rhokiinsa/2477111/Aerie Pharmaceuticals announced the European Commission (EC) has granted a marketing authorization for Rhokiinsa (netarsudil ophthalmic solution) 0.02% for the reduction of elevated IOP in adult patients with primary open-angle glaucoma or ocular hypertension. The marketing authorization a
- Lightmed Introduces New Design of LIGHTLas TruScan Pro Photocoagulatorhttps://modernod.com/news/lightmed-introduces-new-design-of-lightlas-truscan-pro-photocoagulator/2477108/Lightmed announced the launch of LIGHTLas TruScan Pro V2.0, the advanced and flexible pattern-scanning laser that’s configurable with up to four different wavelengths. The upgraded LIGHTLas TruScan Pro V2.0 features a slit lamp and integrated delivery system design, and a new ergonomic single col
- Baring Private Equity Asia Agrees to Acquire Lumenishttps://modernod.com/news/baring-private-equity-asia-agrees-to-acquire-lumenis/2477103/Baring Private Equity Asia announced that its affiliated private equity funds have agreed to acquire Lumenis, a leading provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT and gynecology from XIO. The transaction values Lumenis at an ent
- Nidek Launches the YC-200 and YC-200 S Plus in the United Stateshttps://modernod.com/news/nidek-launches-the-yc-200-and-yc-200-s-plus-in-the-united-states/2477101/Nidek has announced that the FDA has issued 510(k) clearance for the YC-200 Ophthalmic YAG Laser System. The YC-200 includes the S plus model for Selective Laser Trabeculoplasty (SLT). With FDA clearance, the YC-200 and YC-200 S plus are now commercially available in the United States. The
- NovaBay Pharmaceuticals Launches NovaSight Daily Vitamin for Ocular Health on Amazon.comhttps://modernod.com/news/novabay-pharmaceuticals-launches-novasight-daily-vitamin-for-ocular-health-on-amazon-com/2477099/NovaBay Pharmaceuticals announced the launch of NovaSight, a proprietary daily vitamin and mineral supplement specially formulated to support ocular health, on Amazon.com. NovaSight is a companion product to Avenova Direct, NovaBay’s prescription-strength lid and lash spray available on Amazon.co